Infantile hemangiomas: a 7-year experience of a single-center

Authors

  • Mădălina Bota
  • Gheorghe Popa
  • Cristina Lucia Blag
  • Daniel-Corneliu Leucuța
  • Alexandru Tătaru

DOI:

https://doi.org/10.15386/cjmed-781

Keywords:

infantile hemangioma, risk factors, treatment, evolution

Abstract

Objectives. The aim of the study was to describe the historical and clinical characteristics of hemangiomas in a series of cases of our clinic.

Methods. This is a retrospective study of 36 patients with infantile hemangiomas consulted in our clinic.

Results. We had 14 multiple hemangiomas, and 1 kaposiform hemangioendothelioma. Almost two-thirds involved the cephalic extremity, and 76% of the cases were treated. Pregnancy risk factors included prematurity, low-birth weight and respiratory distress syndrome. Propranolol was used in 22 cases, followed by prednisone in 3 cases. Vincristine and interferon were used as associated therapies or as second line therapies. Two hemangiomas had complications, one ulceration and a Kasabach-Merritt syndrome. All the patients had a good evolution.

Conclusions. Our study results regarding the involvement of pregnancy and birth risk factors in developing infantile hemangiomas is similar to literature data. The majority of patients had at least one risk factor suggesting that at least one trigger to develop an infantile hemangioma is necessary. Our study shows that the cephalic extremity is mostly involved, and because of its potential complications they are most likely to be treated. The study shows that propranolol is the leading treatment option with few and mild side effects.

Author Biographies

Mădălina Bota, University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj Napoca, Department of Pediatrics II

Children's Hospital Cluj Napoca, Department of Pediatrics II

Gheorghe Popa, University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj Napoca, Department of Pediatrics II

Children's Hospital Cluj Napoca, Department of Pediatrics II

Cristina Lucia Blag, University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj Napoca, Department of Pediatrics II

Children's Hospital Cluj Napoca, Department of Pediatrics II

Daniel-Corneliu Leucuța, University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj Napoca, Department of Pediatrics II

Department of Informatics and Biostatistics

Alexandru Tătaru, University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj Napoca, Department of Pediatrics II

Department of Dermatology

Downloads

Published

2017-10-30

How to Cite

1.
Bota M, Popa G, Blag CL, Leucuța D-C, Tătaru A. Infantile hemangiomas: a 7-year experience of a single-center. Med Pharm Rep [Internet]. 2017 Oct. 30 [cited 2025 Oct. 6];90(4):396-400. Available from: https://medpharmareports.com/index.php/mpr/article/view/781

Issue

Section

Original Research